AKEBIA THERAPEUTICS INC
AKBA·00972D105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AKBA (AKEBIA THERAPEUTICS INC) is held by 101 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($22.8M), VANGUARD CAPITAL MANAGEMENT LLC ($12.9M), AQR CAPITAL MANAGEMENT LLC ($10.4M). Net institutional sentiment: Mixed.
101
Holders
(8 Elite)
$111.4M
Total Value
64% (107)
Consensus
68 buying - 39 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Aug 10, 2026 · Activists May 12, 2026 · Congress none
InsiderBPButler John P.Exercise 350K shAug 6, 2026
InsiderOEOstrowski ErikSell $62KJun 29, 2026
InsiderRWROGERS MICHAEL WVest 36K shJun 17, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 115
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer